Orange Book product · Generic (ANDA)
CEPHALEXIN
CEPHALEXIN
At a glance
Jun 16, 1987
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 16, 1987
39 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
CEPHALEXIN
Strength
EQ 250MG BASE/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 062768
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEPHALEXIN
- —KEFLEXBrand (NDA)
NDA 050405 · PRAGMA
- —KEFLEXBrand (NDA)
NDA 050406 · PRAGMA
- 2026CEPHALEXINGeneric (ANDA)
ANDA 213568 · AUROBINDO PHARMA
- 2024CEPHALEXINGeneric (ANDA)
ANDA 218947 · ALKEM LABS LTD
- 2024CEPHALEXINGeneric (ANDA)
ANDA 218817 · AUROBINDO PHARMA LTD
- 2019CEPHALEXINGeneric (ANDA)
ANDA 210221 · ALKEM LABS LTD
- 2010CEPHALEXINGeneric (ANDA)
ANDA 090836 · ALKEM LABS LTD
- 2009CEPHALEXINGeneric (ANDA)
ANDA 065444 · HIKMA PHARMS
- 2007CEPHALEXINGeneric (ANDA)
ANDA 065336 · YUNG SHIN PHARM
- 2006CEPHALEXINGeneric (ANDA)
ANDA 065326 · CHARTWELL RX
- 2006CEPHALEXINGeneric (ANDA)
ANDA 065215 · HIKMA
- 2005CEPHALEXINGeneric (ANDA)
ANDA 065229 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
